Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart)

Circulation

Volumn 98, Issue 15, 1998, Pages 1510-1516

  Nolan, James ^a,d   Batin, Phillip D ^a   Andrews, Richard ^b   Lindsay, Steven J ^a   Brooksby, Paul ^b   Mullen, Michael ^c   Baig, Wazir ^c   Flapan, Andrew D ^e   Cowley, Alan ^b   Prescott, Robin J ^e   Neilson, James M M ^e   Fox, Keith A A ^e  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c DONCASTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^e NONE

Author keywords

Heart failure; Heart rate; Mortality

Indexed keywords

CREATININE; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE SIZE; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RR INTERVAL; SODIUM BLOOD LEVEL; SUDDEN DEATH;

EID: 0032514658     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.15.1510     Document Type: Article

References (44)

1. Sanderson J. The sword of Damocles. Lancet. 1996;348:2-3.
2. Cohn JN. The management of chronic heart failure. N Engl J Med. 1996;335:490-498.
3. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R. Ejection fraction, peak oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation. 1993;87(suppl VI):VI-5-VI-16.
4. Johnson G, Carson P, Francis GS, Cohn JN. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by Enalapril: Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). Circulation. 1993;87(suppl VI): VI-32-VI-39.
5. Rector TS, Cohn JN. Prognosis in congestive heart failure. Annu Rev Med. 1994;45:341-350.
6. Cleland JGF, Dargie HJ, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987;58:572-582.
7. Carson P, Johnson G, Fleteher R, Cohn J. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT). J Am Coll Cardiol. 1996;27:642-649.
8. Nolan J. Studies of the Parasympathetic Nervous System in Chronic Heart Failure [MD thesis]. Leeds, UK: University of Leeds; 1996.
9. Nolan J, Flapan AD, Capewell S, MacDonald T, Neilson JMM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J. 1992;67:482-486.
10. Tuininga YS, van Veldhuisen DJ, Brouwer J, Haaksma J, Crijus HJGM, Man in 't Veld AJ, Lie KI. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J. 1994;72:509-513.
11. Ratin PD, Nolan J. Assessment of autonomic function: reflex testing or variability analysis? J Amb Mon. 1996; 9: 255-273.
12. Nolan J, Flapan AD, Goodefield NE, Prescott RJ, Bloomfield P, Neilson JMM, Ewing DJ. Measurement of parasympathetic activity from 24-hour ambulatory electrocardiograms and its reproducibility and sensitivity in normal subjects, patients with symptomatic myocardial ischemia, and patients with diabetes mellitus. Am J Cardiol. 1996;77:154-158.
13. Nolan J, Flapan AD, Reid J, Neilson JMM, Bloomfield P, Ewing DJ. Cardiac parasympathetic activity in severe uncomplicated coronary artery disease. Br Heart J. 1994;71:515-520.
14. The Task Force on Heart Failure at the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J. 1995;16: 741-751.
15. Greene H, Richardson D, Barker A, Roden D, Capone R, Echt D, Friedman L, Gillespie M, Hallstrom A, Vener J, and the CAPS Investigators. Classification of deaths after myocardial infarction as arrhythmic or non-arrhythmic. Am J Cardiol. 1989;63:1-6.
16. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
17. Kleiger RE, Miller JP, Bigger JT Jr, Moss MJ, and the Multicentre Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
18. Zuanetti G, Neilson JMM, Latini R, Santoro E, Maggioni AP, Ewing DJ. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Circulation. 1996;94:432-436.
19. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
20. Szabo BM, van Veldhuisen DJ, van der Veer N, Brouwer J, De Graeff PA, Crijus HJ Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischaemic dilated cardiomyopathy. Am J Cardiol. 1997;79:978-980.
21. Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Haaksman J, Dijk A, Visser KR, Buosma F, Dunselman PH, Lie KI. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. J Am Coll Cardiol. 1996;28:1183-1189.
22. Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabeck K, Coats AJ. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997;79:1645-1650.
23. Binder T, Freys B, Porenta G, Heinz G, Wutte M, Kreiner G, Gossinger H, Schmidinger H, Pacher R, Weber H. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. Pacing Clin Elecrrophysiol. 1992;15:2215-2220.
24. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84: 482-492.
25. Parati G, Saul JP, Di Rieuzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension. 1995;25:1276-1286.
26. Ponikowski P, Chua TP, Amadi AA, Piepoli M, Harrington D, Volterani M, Colombo R, Mazzuero G, Giordani A, Coats AJS. Detection and significance of a discrete very low frequency rhythm in RR interval variability in chronic congestive heart failure. Am J Cardiol. 1996;77: 1320-1326.
27. Mortara A, Sleight P, Pinna GD, Maestri R, Prpa A, La Rouvere MT, Cobelli F, Tavazzi L. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomie tone by measures of heart rate variability. Circulation. 1997;96:246-252.
28. Bernadi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res. 1996;32:234-237.
29. Doval HC, Nul DR, Grancelli HO, Varini SD, Soifer S, Corrado G, Dubner S, Scapin O, Perrone SV. Non-sustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation. 1996;94:3198-3203.
30. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85:163-171.
31. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478-484.
32. Luu M, Stevenson W, Stevenson L, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675-1680.
33. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation. 1991;84: 40-48.
34. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Shaveley DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
35. Moss AJ, Hall WJ, Cannon DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicentre Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
36. Pousset F, Copie X, Lechat P, Jaillon P, Boissel JP, Hetzel M, Fillette F, Remme W, Guize L, Le Heuzey JY. Effects of bisoprolol on heart rate variability in heart failure. Am J Cardiol. 1996;77:612-617.
37. La Rovere MT, Mortara A, Pantaleo P, Maestri R, Cobelli F, Tavazzi L. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation. 1994;90:838-843.
38. Adamopoulos S, Ponikowski P, Cerquetani E, Piepoli M, Rosano G, Sleight P, Coats A. Circadian pattern of heart rate variability in chronic heart failure patients: effects of physical training. Eur Heart J. 1995;16: 1380-1386.
39. You-huaz Z, You-cheng S, Zuu Z, Xian-qi Y. Sympathetic inhibition with clonidine improves autonomie balance in congestive heart failure. Int J Cardiol. 1997;59:139-144.
40. Slatton ML, Irani WN, Hall SA, Marcoux LG, Page RL, Grayburn PA, Eichhorn EJ. Does digoxin provide additional hemodynamic and autonomie benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol. 1997;29: 1206-1213.
41. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
42. Australia/New Zealand Heart Failure Research Collaborative Group. Randomised placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 1997;349: 375-380.
43. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336: 525-533.
44. Redwood SK, Odemuyiwa O, Hnatkova K, Staunton A, Poloniecki J, Camm AJ, Malik M. Selection of dichotomy limits for multifactorial prediction of arrhythmic events and mortality in survivors of acute myocardial infarction. Eur Heart J. 1997;18:1278-1287.